Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 5, 2013, Pages 1197-1209

  Fields, Jerel ^a   Dumaop, Wilmar ^a   Adame, Anthony ^b   Ellis, Ronald J ^b   Letendre, Scott ^c   Grant, Igor ^d   Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; ESCRT; HIV; ISG 15; VPS 4 and LIP 5

Indexed keywords

ESCRT PROTEIN; INTERFERON STIMULATED GENE 15; LIVER ENRICHED INHIBITORY PROTEIN 5; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG; VACUOLAR PROTEIN SORTING 4;

ADULT; ARTICLE; BRAIN; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIP; MALE; MIDDLE AGED; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN TARGETING; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING;

ADULT; AIDS DEMENTIA COMPLEX; AUTOPSY; BIOLOGICAL MARKERS; BRAIN; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; HIV-1; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; VIRAL LOAD; VIRUS REPLICATION;

EID: 84891373653     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9511-3     Document Type: Article

References (40)

1. Centers for Disease Control. HIV/AIDS surveillance report.1-54
2. Babst M, Odorizzi G, Estepa EJ, Emr SD (2000) Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1:248-258
3. Budka H, Costanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R, Vago L (1987) Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol (Berl) 75:185-198
4. Chen HF, Liu XY (2008) The action of TSG101 on HIV-1 budding and related inhibitors. Yao Xue Xue Bao Acta Pharma Sin 43:1165-1170
5. Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, Masliah E, Grant I (2007) Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol 13:23-28
6. Demirov DG, Ono A, Orenstein JM, Freed EO (2002) Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci U S A 99:955-960
7. Dupre S, Volland C, Haguenauer-Tsapis R (2001) Membrane transport: ubiquitylation in endosomal sorting. Curr Biol 11:R932-934
8. Everall I, Salaria S, Roberts E, Corbeil J, Sasik R, Fox H, Grant I, Masliah E (2005) Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol 170:158-171
9. Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, Masliah E, Commins DL, Brandt D, Grant I, Singer EJ, Levine AJ, Miller J, Winkler JM, Fox HS, Luxon BA, Morgello S (2012) The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One 7:e46178
10. Gendelman H, Lipton S, Tardieu M, Bukrinsky M, Nottet H (1994) The neuropathogenesis of HIV-1 infection. J Leukocyte Biol 56:389-398
11. Gerena Y, Skolasky RL, Velez JM, Toro-Nieves D, Mayo R, Nath A, Wojna V (2012) Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS One 7:e37358
12. Grover JR, Llewellyn GN, Soheilian F, Nagashima K, Veatch SL, Ono A (2013) Roles played by capsid-dependent induction of membrane curvature and Gag-ESCRT interactions in tetherin recruitment to HIV-1 assembly sites. J Virol 87:4650-4664
13. Hashimoto M, Sagara Y, Everall IP, Mallory M, Everson A, Langford D, Masliah E (2002) Fibroblast growth factor 1 regulates signaling via the GSK3{beta} pathway: implications for neuroprotection. J Biol Chem 277:32985-32991
14. Havlir DV, Currier JS (2006) Complications of HIV disease and antiretroviral therapy. Top HIV Med Publ Int AIDS Soc USA 14:27-35
15. Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z (2008) Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol 14:536-549
16. Heaton RK et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-2096
17. Heaton RK et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
18. Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ (2010) Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol 16:101-114
19. Jouvenet N (2012) Dynamics of ESCRT proteins. Cell Mol Life Sci 69:4121-4133
20. Katsounas A, Hubbard JJ, Wang CH, Zhang X, Dou D, Shivakumar B, Winter S, Schlaak JF, Lempicki RA, Masur H, Polis M, Kottilil S, Osinusi A (2013) High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV. J Med Virol 85:959-963
21. Kuang Z, Seo EJ, Leis J (2011) Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J Virol 85:7153-7161
22. Langelier C, von Schwedler UK, Fisher RD, De Domenico I, White PL, Hill CP, Kaplan J, Ward D, Sundquist WI (2006) Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J Virol 80:9465-9480
23. Li Y, Kane T, Tipper C, Spatrick P, Jenness DD (1999) Yeast mutants affecting possible quality control of plasma membrane proteins. Mol Cell Biol 19:3588-3599
24. Lichtfuss GF, Hoy J, Rajasuriar R, Kramski M, Crowe SM, Lewin SR (2011) Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection. Biomark Med 5:171-186
25. Masliah E, Alford M, Adame A, Rockenstein E, Galasko D, Salmon D, Hansen LA, Thal LJ (2003) Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Neurology 61:206-211
26. Merino JJ, Montes ML, Blanco A, Bustos MJ, Oreja-Guevara C, Bayon C, Cuadrado A, Lubrini G, Cambron I, Munoz A, Cebolla S, Gutierrez-Fernandez M, Bernardino JI, Arribas JR, Fiala M (2011) HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system. Rev Neurol 52:101-111
27. Montaner JS, Cote HC, Harris M, Hogg RS, Yip B, Chan JW, Harrigan PR, O'Shaughnessy MV (2003) Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy. J Acquir Immune Defic Syndr 34(Suppl 1):S85-90
28. Nakka VP, Lang BT, Lenschow DJ, Zhang DE, Dempsey RJ, Vemuganti R (2011) Increased cerebral protein ISGylation after focal ischemia is neuroprotective. J Cereb Blood Flow Metab 31:2375-2384
29. Okumura A, Lu G, Pitha-Rowe I, Pitha PM (2006) Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A 103:1440-1445
30. Pendyala G, Want EJ, Webb W, Siuzdak G, Fox HS (2007) Biomarkers for neuroAIDS: the widening scope of metabolomics. J Neuroimmune Pharmacol 2:72-80
31. Pincetic A, Kuang Z, Seo EJ, Leis J (2010) The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol 84:4725-4736
32. Poteet E, Choudhury GR, Winters A, Li W, Ryou MG, Liu R, Tang L, Ghorpade A, Wen Y, Yuan F, Keir ST, Yan H, Bigner DD, Simpkins JW, Yang SH (2013) Reversing the Warburg effect as a treatment for glioblastoma. J Biol Chem 288:9153-9164
33. Sharma TS, Jacobson D, Anderson LM, Gerschenson M, Vandyke R, McFarland E, Miller T (2013) The Relationship between Mitochondrial Dysfunction and Insulin Resistance in HIV-infected Children Receiving Antiretroviral Therapy. AIDS Res Hum Retroviruses 29(9):1211-1217
34. Shim S, Merrill SA, Hanson PI (2008) Novel interactions of ESCRT-III with LIP5 and VPS4 and their implications for ESCRT-III disassembly. Mol Biol Cell 19:2661-2672
35. Skaug B, Chen ZJ (2010) Emerging role of ISG15 in antiviral immunity. Cell 143:187-190
36. Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, Adame A, Wyss-Coray T, Masliah E (2009) Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J Neurosci 29:13578-13588
37. Strathdee SA, O'Shaughnessy MV, Montaner JS, Schechter MT (1996) A decade of research on the natural history of HIV infection: Part 1. Markers. Clin Invest Med Med Clin Exp 19:111-120
38. VerPlank L, Bouamr F, LaGrassa TJ, Agresta B, Kikonyogo A, Leis J, Carter CA (2001) Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A 98:7724-7729
39. Wang RG, Kaul M, Zhang DX (2012) Interferon-stimulated gene 15 as a general marker for acute and chronic neuronal injuries. Sheng Li Xue Bao Acta Physiol Sin 64:577-583
40. Ward DM, Vaughn MB, Shiflett SL, White PL, Pollock AL, Hill J, Schnegelberger R, Sundquist WI, Kaplan J (2005) The role of LIP5 and CHMP5 in multivesicular body formation and HIV-1 budding in mammalian cells. J Biol Chem 280:10548-10555